These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1815 related items for PubMed ID: 7563451

  • 1. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH.
    JAMA; 1995 Oct 04; 274(13):1017-25. PubMed ID: 7563451
    [Abstract] [Full Text] [Related]

  • 2. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S.
    JAMA; 1999 Dec 01; 282(21):2019-26. PubMed ID: 10591384
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2012 Dec 01; 34(2):140-6. PubMed ID: 22854333
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S, Toni D, TESPI trial Investigators.
    Int J Stroke; 2012 Apr 01; 7(3):250-7. PubMed ID: 22292526
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L, La Gioia S, Ghidinelli C, Anzalone N, De Filippis C, Comi G.
    J Stroke Cerebrovasc Dis; 2013 Aug 01; 22(6):703-8. PubMed ID: 22133742
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y, Sharma VK, Robinson T, Lindley RI, Chen X, Kim JS, Lavados P, Olavarría V, Arima H, Fuentes S, Nguyen HT, Lee TH, Parsons MW, Levi C, Demchuk AM, Bath PM, Broderick JP, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Pandian J, Ricci S, Stapf C, Woodward M, Wang J, Chalmers J, Anderson CS, ENCHANTED investigators.
    Int J Stroke; 2015 Jul 01; 10(5):778-88. PubMed ID: 25832995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC, Rabinstein AA.
    Cerebrovasc Dis; 2012 Jul 01; 34(2):106-14. PubMed ID: 22868870
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II.
    Dzialowski I, Hill MD, Coutts SB, Demchuk AM, Kent DM, Wunderlich O, von Kummer R.
    Stroke; 2006 Apr 01; 37(4):973-8. PubMed ID: 16497977
    [Abstract] [Full Text] [Related]

  • 15. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
    Rhoney DH, Coplin WM, Lin Y, Frankel M, Lyden PD, Levine SR.
    J Stroke Cerebrovasc Dis; 2010 Jan 01; 19(1):40-8. PubMed ID: 20123226
    [Abstract] [Full Text] [Related]

  • 16. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
    IMS Study Investigators.
    Stroke; 2004 Apr 01; 35(4):904-11. PubMed ID: 15017018
    [Abstract] [Full Text] [Related]

  • 17. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
    Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J, Kasner S, Kidwell C, Kwiatkowski T, Libman R, Mackenzie R, Scott P, Starkman S, Thurman RJ, CLEAR Trial Investigators.
    Stroke; 2008 Dec 01; 39(12):3268-76. PubMed ID: 18772447
    [Abstract] [Full Text] [Related]

  • 18. Acute stroke: usefulness of early CT findings before thrombolytic therapy.
    von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C, Bluhmki E, Ringleb P, Meier DH, Hacke W.
    Radiology; 1997 Nov 01; 205(2):327-33. PubMed ID: 9356611
    [Abstract] [Full Text] [Related]

  • 19. [Intravenous thrombolysis patients with acute ischemic stroke: the analysis of the 100 cases. Part I. Characteristic of the patients and effectiveness of treatment].
    Sobolewski P, Sledzińska M, Szczuchniak W, Hatalska-Zerebiec R, Grzesik M, Sobota A.
    Przegl Lek; 2012 Nov 01; 69(6):237-41. PubMed ID: 23094435
    [Abstract] [Full Text] [Related]

  • 20. European Cooperative Acute Stroke Study (ECASS): (rt-PA-Thrombolysis in acute stroke) study design and progress report.
    Boysen G, ECASS Study Group.
    Eur J Neurol; 1995 Jan 01; 1(3):213-9. PubMed ID: 24283521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.